News
Come and visit us at the Virtual Advanced Therapies Congress 2020!
NPS will be attending the virtual Advanced Therapies Congress & Expo 2020. Come and discuss mycoplasma detection in ATMPs. We look forward to meeting you there....
MycoFinder kit successfully completes EP 2.6.7 validation study
Nissui Pharma Solutions (NPS) has successfully completed an EP validation study in partnership with Confarma, a Solvias group company, specialized in biological analysis. MycoFinder, a mycoplasma gene detection kit, fulfils all requirements for EP 2.6.7. This...
Launch of NPS, Nissui Pharmaceutical (Japan) subsidiary in Europe.
Nissui Pharmaceutical Solutions (NPS) has been created by Nissui Pharmaceutical (Japan) as their European product development, sales and marketing subsidiary. Headquartered in Paris, NPS will develop and market products across Europe as part of the international...
NPS
NPS provides innovative solutions for QC/QA and product release of ATMPs and biopharmaceuticals.
Contact us
Nissui Pharma Solutions
10, rue Mesnil
75116, Paris
France
Sales : contact@nissui-ps.com
Technical support : support@nissui-ps.com
*Required fields
For any information concerning the protection of personal data, please consult our privacy policy.
Copyright © Nissui Pharmasolutions, All rights reserved - Legal & credits - Terms of sales
Design by B-to-B Design